Cwm, LLC 10x Genomics, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 22,810 shares of TXG stock, worth $326,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,810

Previous 4,189 444.52%

Holding current value

$326,411

Previous $81,000 535.8%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$15.71 - $23.49 $292,535 - $437,407	18,621 Added 444.52%	22,810 $515,000
Q2 2024 Jul 09, 2024	SELL	$19.45 - $37.37 $857,103 - $1.65 Million	-44,067 Reduced 91.32%	4,189 $81,000
Q1 2024 Apr 05, 2024	SELL	$36.08 - $54.3 $414,450 - $623,744	-11,487 Reduced 19.23%	48,256 $1.81 Million
Q4 2023 Feb 01, 2024	SELL	$34.32 - $57.55 $117,305 - $196,705	-3,418 Reduced 5.41%	59,743 $3.34 Million
Q3 2023 Oct 11, 2023	SELL	$40.86 - $62.98 $94,059 - $144,979	-2,302 Reduced 3.52%	63,161 $2.61 Million
Q2 2023 Aug 03, 2023	SELL	$50.96 - $58.72 $187,379 - $215,913	-3,677 Reduced 5.32%	65,463 $3.66 Million
Q1 2023 Apr 28, 2023	BUY	$35.33 - $55.79 $2.4 Million - $3.79 Million	67,955 Added 5734.6%	69,140 $3.86 Million
Q4 2022 Feb 01, 2023	BUY	$24.4 - $41.3 $9,491 - $16,065	389 Added 48.87%	1,185 $43,000
Q3 2022 Oct 27, 2022	BUY	$28.48 - $52.59 $9,654 - $17,828	339 Added 74.18%	796 $23,000
Q2 2022 Jul 28, 2022	SELL	$36.95 - $82.41 $249,597 - $556,679	-6,755 Reduced 93.66%	457 $21,000
Q1 2022 Apr 21, 2022	SELL	$55.7 - $145.79 $54,808 - $143,457	-984 Reduced 12.01%	7,212 $549,000
Q4 2021 Jan 31, 2022	BUY	$135.05 - $182.59 $1.11 Million - $1.5 Million	8,196 New	8,196 $1.22 Million

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.36B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account